Boston Scientific accounts are for healthcare professionals only.
VersaCross™ Access Solution
Configure or select a product to continue to order
- Overview
- Clinical data
- Technical specifications
- Ordering information
- Training
- Resources
Transseptal reimagined
Exchangeless solution for access-to-delivery of left heart therapy devices
How it works
The VersaCross RF Transseptal Platform includes an insulated RF Wire, reinforced shapeable dilator, and dedicated RFP-100A RF Puncture Generator* for predictable and efficient left heart access, with fewer and lower energy applications required to achieve successful transseptal puncture compared to electrified guidewires or needles.1,2
Why choose the VersaCross Access Solution
Three solutions, one device
Know where you are at all times
OMNIviz™ technology enhances visualization on fluoroscopy, ultrasound, and electrical anatomical mapping
What’s included
The VersaCross Access Solution includes:
- VersaCross RF Wire (j-tip or pigtail)
- Single-use RFP-100A Connector Cable
- VersaCross Transseptal Sheath (8.5F)
- Dilator with TRUform™ shapeable technology
You can also purchase the VersaCross Transseptal Sheath on its own.
Required product
Designed for controlled tissue puncture using radiofrequency energy
Clinical highlights
November 2022, Dewland et al., published in JACC: Clinical Electrophysiology
Randomized comparison of a radiofrequency wire versus a radiofrequency needle system for transseptal puncture
RF wire-based transseptal workflow resulted in a faster time to transseptal puncture, with fewer exchanges for RF ablation, compared to an RF needle-based workflow.
Publication summaries
March 2025, Al-Ahmad et al., published in Journal of Cardiovascular Electrophysiology
The VersaCross RF Wire and dedicated RFP-100A RF Puncture Generator* achieved 100% transseptal puncture success with only 1 RF application, compared to an electrified guidewire with long uninsulated electrode and standard electrosurgical generator, which required up to 5 RF applications and did not consistently achieve puncture at 30-40 W.
October 2023, Knight et al., published in Journal of Cardiovascular Electrophysiology
In an ex vivo study, mechanical puncture using the FlexCath Cross™ (formerly known as AcQCross™)† Transseptal Solution required more force and device advancement than purpose-built radiofrequency (RF) puncture with the VersaCross™ RF Transseptal Solution.
June 2023, Doshi et al., published in Structural Heart
When compared to a standard mechanical needle-based workflow, the VersaCross RF Wire-based workflow enabled faster TSP (transseptal puncture) and PASCAL™ Implant release,‡ with fewer exchanges required to streamline mitral transcatheter edge-to-edge repair (M-TEER) procedures.
January 2023, Whitler et al., published in Catheterization and Cardiovascular Interventions
Transseptal puncture using the VersaCross Access Solution allowed for fewer device exchanges and lower fluoroscopy usage, leading to an overall more streamlined and efficient WATCHMANTM left atrial appendage closure (LAAC) procedure than with the standard NRGTM RF needle workflow.
November 2022, Dewland et al., published in JACC: Clinical Electrophysiology
RF wire-based transseptal workflow resulted in a faster time to transseptal puncture, with fewer exchanges for RF ablation, compared to an RF needle-based workflow.
February 2022, Demo et al., published in Journal of Interventional Cardiac Electrophysiology
The VersaCross RF Transseptal Solution enabled fluoroless transseptal puncture in ablation procedures, with average transseptal puncture time under 20 minutes and zero exchanges required for transseptal puncture.
January 2021, Inohara et al., published in Journal of Interventional Cardiac Electrophysiology
LAAC sheath delivery was two times faster using the VersaCross RF Transseptal Solution than the conventional workflow.
November 2020, Sayah et al., published in Catheterization and Cardiovascular Interventions
The VersaCross RF Transseptal Solution enabled MitraClip™ Guide delivery in under 7.5 minutes.
VersaCross RF Wire
| Feature | Specifications |
| Tip configurations | J-tip, pigtail |
| Curve shape | 9 mm (j-tip), 24 mm (pigtail) |
| Wire diameter | 0.035" |
| Overall length | 180 cm, 230 cm |
VersaCross Transseptal Sheath
| Feature | Specifications |
| French size | 8.5F |
| Sheath usable length | 63 cm, 81 cm |
| Sheath curves | 45°, 55°, 90° |
| Dilator usable length | 67 cm, 85 cm |
| Dilator curve | D0, D1 |
Ordering information
| 1. Choose your VersaCross RF Wire |
J-tip, pigtail
| VersaCross RF Wire |
| RF wire length: 180 cm, 230 cm |
| Wire diameter: 0.035" |
| Curve diameter: 9 mm (j-tip), 24 mm (pigtail) |
| 2. Choose your sheath to complete your solution |
45°, 55°, 90°
| VersaCross Transseptal Sheath |
| French size compatibility: 8.5F (2.84 mm) |
| Sheath usable length: 63 cm, 81 cm |
| Dilator usable length: 67 cm, 85 cm |
In-person training
Explore in-person training opportunities for electrophysiologists and interventional cardiologists of all experience levels.
Online education
Utilizing RF for Transseptal Puncture
Bradley Knight, MD, shares an overview and techniques of the VersaCross RF Transseptal Solution.
Optimizing EP Lab Efficiency for Cryoablation Procedures
Manish Shah, MD, shares his experience using the VersaCross RF Transseptal Solution.
A New RF Wire Based Transseptal Solution
Originally presented at CSI 2020, Jacqueline Saw, MD, shares step-by-step clinical workflows and latest tools for efficient and precise transseptal puncture.
On-site transseptal simulator training
Hands-on training on the use of RF-based transseptal platforms in various clinical scenarios using virtual reality technology, echocardiography simulators, and anatomical models.
Online medical training and education courses
The EDUCARE online platform makes healthcare education and training more relevant, more comprehensive, more personal, and more accessible. Register to access a library of procedural videos, case studies, training resources, and events.
Detail package
Brochures
Analysis
Video
Clinical footage of the VersaCross Access Solution, a single solution to fast-track access-to-delivery of therapy devices
Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.The VersaCross Access Solution enabling efficient, exchangeless, and effortless access-to-delivery of a left atrial appendage occlusion (LAAO) device
* Baylis Medical Company Radiofrequency Puncture Generator RFP-100A. Baylis Medical Company is a wholly owned subsidiary of Boston Scientific Corporation.
† AcQCross™ Transseptal Access System, now rebranded as FlexCath Cross™ Transseptal Solution, Medtronic.
‡ The PASCAL™ Implant is part of the PASCAL Precision™ Transcatheter Valve Repair System.
All trademarks are the property of their respective owners.
References:
1 Knight BP, Wasserlauf J, Al-Dujaili S, Al-Ahmad A. Comparison of transseptal puncture using a dedicated RF wire versus a mechanical needle with and without electrification in an animal model. J Cardiovasc Electrophysiol. 2023. doi:10.1111/jce.16111
2 Wasserlauf J, Knight BP. Comparing the safety and effectiveness of dedicated radiofrequency transseptal wires to electrified metal guidewires. J Cardiovasc Electrophysiol. 2022;33(3):371-379. doi:10.1111/jce.15341